Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily R Hankosky

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Behavioural Brain Research|May 2, 2018
Age- and sex-dependent effects of methamphetamine on cognitive flexibility and 5-HT<sub>2C</sub> receptor localization in the orbitofrontal cortex of Sprague-Dawley ratsEmily R Hankosky, Sara R Westbrook, Rachel M Haake, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 19, 2021
The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: "What am I going to do?"Heather L Stuckey, Urvi Desai, Sarah B King, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Pharmacoeconomics|June 6, 2022
A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 DiabetesÁgnes Benedict, Emily R Hankosky, Kinga Marczell, et al.
Diabetes, Obesity & Metabolism|November 6, 2023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysisEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
Diabetes Research and Clinical Practice|May 2, 2024
Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world settingRobert Brett McQueen, Magaly Perez-Nieves, G Todd Alonso, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Retrospective analysis of health claims to evaluate pharmacotherapies with potential for repurposing: Association of bupropion and stimulant use disorder remissionEmily R Hankosky, Heather M Bush, Linda P Dwoskin, et al.
Nutritional Neuroscience|February 21, 2016
Effects of β-hydroxy-β-methyl butyrate on working memory and cognitive flexibility in an animal model of agingEmily R Hankosky, Luke K Sherrill, Lauren A Ruvola, et al.
2018 IEEE International Conference on Healthcare Informatics Workshops : Proceedings : 4-7 June 2018, New York, NY. International Conference on Healthcare Informatics (6Th : 2018 : New York, N.Y.). Workshops|August 6, 2019
Predicting Substance Use Disorder in ADHD Patients using Long-Short Term Memory ModelSajjad Fouladvand, Emily R Hankosky, Darren W Henderson, et al.
Health Informatics Journal|May 21, 2019
Predicting substance use disorder using long-term attention deficit hyperactivity disorder medication records in TruvenSajjad Fouladvand, Emily R Hankosky, Heather Bush, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Behavioural Brain Research|May 2, 2018
Age- and sex-dependent effects of methamphetamine on cognitive flexibility and 5-HT<sub>2C</sub> receptor localization in the orbitofrontal cortex of Sprague-Dawley ratsEmily R Hankosky, Sara R Westbrook, Rachel M Haake, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 19, 2021
The experience of a severe hypoglycaemic event from the perspective of people with diabetes and their caregivers: "What am I going to do?"Heather L Stuckey, Urvi Desai, Sarah B King, et al.
Diabetes & Metabolism|March 8, 2025
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United StatesEmily R Hankosky, Karishma Desai, Chanadda Chinthammit, et al.
Pharmacoeconomics|June 6, 2022
A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 DiabetesÁgnes Benedict, Emily R Hankosky, Kinga Marczell, et al.
Diabetes, Obesity & Metabolism|November 6, 2023
Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysisEmily R Hankosky, Hui Wang, Lisa M Neff, et al.
Diabetes Research and Clinical Practice|May 2, 2024
Association between continuous glucose monitoring metrics and clinical outcomes in adults with type 1 diabetes in a real-world settingRobert Brett McQueen, Magaly Perez-Nieves, G Todd Alonso, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Retrospective analysis of health claims to evaluate pharmacotherapies with potential for repurposing: Association of bupropion and stimulant use disorder remissionEmily R Hankosky, Heather M Bush, Linda P Dwoskin, et al.
Nutritional Neuroscience|February 21, 2016
Effects of β-hydroxy-β-methyl butyrate on working memory and cognitive flexibility in an animal model of agingEmily R Hankosky, Luke K Sherrill, Lauren A Ruvola, et al.
2018 IEEE International Conference on Healthcare Informatics Workshops : Proceedings : 4-7 June 2018, New York, NY. International Conference on Healthcare Informatics (6Th : 2018 : New York, N.Y.). Workshops|August 6, 2019
Predicting Substance Use Disorder in ADHD Patients using Long-Short Term Memory ModelSajjad Fouladvand, Emily R Hankosky, Darren W Henderson, et al.
Health Informatics Journal|May 21, 2019
Predicting substance use disorder using long-term attention deficit hyperactivity disorder medication records in TruvenSajjad Fouladvand, Emily R Hankosky, Heather Bush, et al.
Pageof 4